# Scholar Rock wins first FDA approval for rare muscle-wasting disease

https://mins.news/en/item/55320

- Reuters, 2026-09-11 23:50 UTC
- Health
- Original: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-scholar-rocks-muscle-weakness-drug-2026-09-11/?link_source=ta_bluesky_link&taid=6aa493afb45a8a0001234c0a

> The U.S. Food and Drug Administration approved Scholar Rock’s therapy on Friday for a rare genetic condition that causes muscle weakness, giving the company its first regulatory approval.